FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064831267> ?p ?o ?g. }

• W2064831267 endingPage "1012" @default.
• W2064831267 startingPage "1005" @default.
• W2064831267 abstract "Abstract Although imatinib, a BCR-ABL tyrosine kinase inhibitor, is used to treat acute Philadelphia chromosome–positive (Ph+) leukemia, it does not prevent central nervous system (CNS) relapses resulting from poor drug penetration through the blood-brain barrier. Imatinib and dasa-tinib (a dual-specific SRC/BCR-ABL kinase inhibitor) were compared in a preclinical mouse model of intracranial Ph+ leukemia. Clinical dasatinib treatment in patients with CNS Ph+ leukemia was assessed. In preclinical studies, dasatinib increased survival, whereas imatinib failed to inhibit intracranial tumor growth. Stabilization and regression of CNS disease were achieved with continued dasa-tinib administration. The drug also demonstrated substantial activity in 11 adult and pediatric patients with CNS Ph+ leukemia. Eleven evaluable patients had clinically significant, long-lasting responses, which were complete in 7 patients. In 3 additional patients, isolated CNS relapse occurred during dasatinib therapy; and in 2 of them, it was caused by expansion of a BCR-ABL–mutated dasatinib-resistant clone, implying selection pressure exerted by the compound in the CNS. Dasatinib has promising therapeutic potential in managing intracranial leukemic disease and substantial clinical activity in patients who experience CNS relapse while on imatinib therapy. This study is registered at ClinicalTrials.gov as CA180006 (#NCT00108719) and CA180015 (#NCT00110097)." @default.
• W2064831267 created "2016-06-24" @default.
• W2064831267 creator A5000436961 @default.
• W2064831267 creator A5001334651 @default.
• W2064831267 creator A5001565362 @default.
• W2064831267 creator A5004083002 @default.
• W2064831267 creator A5005516784 @default.
• W2064831267 creator A5008868111 @default.
• W2064831267 creator A5009675656 @default.
• W2064831267 creator A5014115612 @default.
• W2064831267 creator A5023859348 @default.
• W2064831267 creator A5028199476 @default.
• W2064831267 creator A5033314197 @default.
• W2064831267 creator A5035197183 @default.
• W2064831267 creator A5038223232 @default.
• W2064831267 creator A5050873337 @default.
• W2064831267 creator A5051537989 @default.
• W2064831267 creator A5057695659 @default.
• W2064831267 creator A5061935273 @default.
• W2064831267 creator A5062230211 @default.
• W2064831267 creator A5064103067 @default.
• W2064831267 creator A5066026746 @default.
• W2064831267 creator A5076623303 @default.
• W2064831267 creator A5081306743 @default.
• W2064831267 creator A5086676382 @default.
• W2064831267 creator A5087175563 @default.
• W2064831267 creator A5090759656 @default.
• W2064831267 date "2008-08-15" @default.
• W2064831267 modified "2023-10-16" @default.
• W2064831267 title "Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia" @default.
• W2064831267 cites W1966233714 @default.
• W2064831267 cites W1968071128 @default.
• W2064831267 cites W1969450923 @default.
• W2064831267 cites W1970962784 @default.
• W2064831267 cites W1973720500 @default.
• W2064831267 cites W1992551728 @default.
• W2064831267 cites W1999644963 @default.
• W2064831267 cites W2003853210 @default.
• W2064831267 cites W2003973314 @default.
• W2064831267 cites W2004492241 @default.
• W2064831267 cites W2012962381 @default.
• W2064831267 cites W2013094135 @default.
• W2064831267 cites W2024771902 @default.
• W2064831267 cites W2035287163 @default.
• W2064831267 cites W2036862498 @default.
• W2064831267 cites W2039201527 @default.
• W2064831267 cites W2047803210 @default.
• W2064831267 cites W2049194757 @default.
• W2064831267 cites W2054722364 @default.
• W2064831267 cites W2055759431 @default.
• W2064831267 cites W2063918186 @default.
• W2064831267 cites W2070683532 @default.
• W2064831267 cites W2079788597 @default.
• W2064831267 cites W2080125373 @default.
• W2064831267 cites W2087430484 @default.
• W2064831267 cites W2092606584 @default.
• W2064831267 cites W2095443553 @default.
• W2064831267 cites W2097946794 @default.
• W2064831267 cites W2098983401 @default.
• W2064831267 cites W2131790261 @default.
• W2064831267 cites W2142536456 @default.
• W2064831267 cites W2148389318 @default.
• W2064831267 cites W2578703009 @default.
• W2064831267 doi "https://doi.org/10.1182/blood-2008-02-140665" @default.
• W2064831267 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18477770" @default.
• W2064831267 hasPublicationYear "2008" @default.
• W2064831267 type Work @default.
• W2064831267 sameAs 2064831267 @default.
• W2064831267 citedByCount "350" @default.
• W2064831267 countsByYear W20648312672012 @default.
• W2064831267 countsByYear W20648312672013 @default.
• W2064831267 countsByYear W20648312672014 @default.
• W2064831267 countsByYear W20648312672015 @default.
• W2064831267 countsByYear W20648312672016 @default.
• W2064831267 countsByYear W20648312672017 @default.
• W2064831267 countsByYear W20648312672018 @default.
• W2064831267 countsByYear W20648312672019 @default.
• W2064831267 countsByYear W20648312672020 @default.
• W2064831267 countsByYear W20648312672021 @default.
• W2064831267 countsByYear W20648312672022 @default.
• W2064831267 countsByYear W20648312672023 @default.
• W2064831267 crossrefType "journal-article" @default.
• W2064831267 hasAuthorship W2064831267A5000436961 @default.
• W2064831267 hasAuthorship W2064831267A5001334651 @default.
• W2064831267 hasAuthorship W2064831267A5001565362 @default.
• W2064831267 hasAuthorship W2064831267A5004083002 @default.
• W2064831267 hasAuthorship W2064831267A5005516784 @default.
• W2064831267 hasAuthorship W2064831267A5008868111 @default.
• W2064831267 hasAuthorship W2064831267A5009675656 @default.
• W2064831267 hasAuthorship W2064831267A5014115612 @default.
• W2064831267 hasAuthorship W2064831267A5023859348 @default.
• W2064831267 hasAuthorship W2064831267A5028199476 @default.
• W2064831267 hasAuthorship W2064831267A5033314197 @default.
• W2064831267 hasAuthorship W2064831267A5035197183 @default.
• W2064831267 hasAuthorship W2064831267A5038223232 @default.
• W2064831267 hasAuthorship W2064831267A5050873337 @default.
• W2064831267 hasAuthorship W2064831267A5051537989 @default.
• W2064831267 hasAuthorship W2064831267A5057695659 @default.

• next